GATINEAU, QC–(Marketwired – July 31, 2017) – The Hydropothecary Corporation (TSX VENTURE: THCX) today began shipping Elixir No. 1, Canada’s first legal medical marijuana sublingual (under tongue) mist in a naturally-derived oil.
The new product contains cannabis oil in a refreshing natural peppermint oil base, and can be used under the tongue, inside the cheek, or mixed with food or liquids. Elixir No. 1 contains close to the maximum allowable THC level of 30mg/ml for a cannabis oil under current Health Canada’s Access to Cannabis for Medical Purposes Regulations.
“With Elixir No. 1, we are offering Canadians a discreet, portable and smoke-free way to take their medicine. The cannabis oil is activated and ready to use. Elixir No. 1 represents our mandate to create innovative, easy to use, easy to understand products that will help even more Canadians,” said Sebastien St-Louis, CEO and co-founder.
Packaged in an exclusive, child-resistant, 15ml bottle, Elixir No. 1 delivers approximately 150 sprays per unit, when used at maximum nozzle depression. Onset occurs in around 30 to 45 minutes. Each bottle has approximately 400 mg of THC per bottle.
Mr. St-Louis noted that the product is the Hydropothecary Corporation’s latest innovation – and its first cannabis oil release.
Elixir No 1 is available at the Hydropothecary’s online store for $89/15ml bottle or by ordering by telephone. Hydropothecary operates a 24/7 bilingual customer service phone line at 1-844-406-1852.
For more information on Elixir No 1, please visit www.thehydropothecary.com/products#
For images and other documents, please click here: www.thc.vc/ElixirMedia *please note that the URL is case sensitive
About The Hydropothecary Corporation (THCX)
The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides naturally grown and rigorously tested medical cannabis of uncompromising quality. Hydropothecary’s branding, cannabis product offering, patient service standards and product pricing are consistent with THCX’s positioning as a premium brand for a legal source for medical cannabis within this new marketplace. In addition to medical cannabis production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical cannabis, as well as the import and export of medical cannabis.
Image Available: http://www.marketwire.com/library/MwGo/2017/7/31/11G143413/Images/Hydropothecary_Elixir_No1_Marijuana_Cannabis_Oil_E-55f2caf70cda855b81bc0f66d4af8860.jpg
For media inquiries please contact:
Julie Beun
Publicist
[email protected]
613-371-9060
For investor relations:
www.THCX.com
1-866-438-THCX (8429)
[email protected]
